NASDAQ: PYPD
Polypid Ltd Stock Forecast, Predictions & Price Target

Analyst price target for PYPD

Based on 2 analysts offering 12 month price targets for Polypid Ltd

Min Forecast
$10.00+263.64%
Avg Forecast
$10.50+281.82%
Max Forecast
$11.00+300%

Should I buy or sell PYPD stock?

Based on 2 analysts offering ratings for Polypid Ltd.

Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PYPD stock forecasts and price targets.

PYPD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-14
lockedlocked$00.00+00.00%2024-11-04

1 of 1

Forecast return on equity

Is PYPD forecast to generate an efficient return?

Company
N/A
Industry
153.19%
Market
81.87%

Forecast return on assets

Is PYPD forecast to generate an efficient return on assets?

Company
N/A
Industry
36.07%

PYPD earnings per share forecast

What is PYPD's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$1.87-138.09%
Avg 2 year Forecast
-$1.16-123.63%

PYPD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PYPD$2.75$10.50+281.82%Buy
GBIO$0.42$8.50+1,938.37%Strong Buy
ALGS$4.62$70.00+1,415.15%Buy
MLEC$0.69N/AN/A
BRNS$0.71$3.00+322.54%Buy

Polypid Stock Forecast FAQ

Is Polypid Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: PYPD) stock is to Buy PYPD stock.

Out of 2 analysts, 0 (0%) are recommending PYPD as a Strong Buy, 2 (100%) are recommending PYPD as a Buy, 0 (0%) are recommending PYPD as a Hold, 0 (0%) are recommending PYPD as a Sell, and 0 (0%) are recommending PYPD as a Strong Sell.

If you're new to stock investing, here's how to buy Polypid stock.

What is PYPD's earnings growth forecast for 2025-2026?

(NASDAQ: PYPD) Polypid's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.

Polypid's earnings in 2025 is -$29,022,000.On average, 1 Wall Street analyst forecast PYPD's earnings for 2025 to be -$19,056,990, with the lowest PYPD earnings forecast at -$19,056,990, and the highest PYPD earnings forecast at -$19,056,990.

In 2026, PYPD is forecast to generate -$11,821,449 in earnings, with the lowest earnings forecast at -$11,821,449 and the highest earnings forecast at -$11,821,449.

What is PYPD's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: PYPD) forecast ROE is N/A, which is considered weak.

What is PYPD's Price Target?

According to 2 Wall Street analysts that have issued a 1 year PYPD price target, the average PYPD price target is $10.50, with the highest PYPD stock price forecast at $11.00 and the lowest PYPD stock price forecast at $10.00.

On average, Wall Street analysts predict that Polypid's share price could reach $10.50 by Apr 14, 2026. The average Polypid stock price prediction forecasts a potential upside of 281.82% from the current PYPD share price of $2.75.

What is PYPD's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: PYPD) Polypid's current Earnings Per Share (EPS) is $4.91. On average, analysts forecast that PYPD's EPS will be -$1.87 for 2025, with the lowest EPS forecast at -$1.87, and the highest EPS forecast at -$1.87. In 2026, PYPD's EPS is forecast to hit -$1.16 (min: -$1.16, max: -$1.16).

What is PYPD's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: PYPD) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 36.07%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.